Experiment 556455

Worktypes

PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

INGENOL,3-O-(DECA-TRANS-2-CIS-4-DIENOYL):

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
IMMUNOSTIMULANT ACTIVITY
OrganismEuphorbia kansui (EUPHORBIACEAE)
CitationMATSUMOTO,T: CHO,S: YAMADA,H:. (1994). INGENOL DERIVATIVE OF EUPHORBIA KANSUI AND FC RECEPTOR FORMATION ENHANCERS CONTAINING INGENOLS.. ()
Amount utilized
Compound isolated
DiseaseINCREASED FC RECEPTOR FORMATION POSSIBLY THROUGH INCREASING GLUCOSE OXIDASE/ANTI-GLUCOSE OXIDASE COMPLEX TO MACROPHAGE.
Number2
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED